Payments to Acquire Property, Plant, and Equipment in USD of Freeline Therapeutics Holdings plc from 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Freeline Therapeutics Holdings plc quarterly/annual Payments to Acquire Property, Plant, and Equipment history and change rate from 2018 to Q1 2023.
  • Freeline Therapeutics Holdings plc Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2023 was $392K, a 25.5% decline year-over-year.
  • Freeline Therapeutics Holdings plc annual Payments to Acquire Property, Plant, and Equipment for 2022 was $7.01M, a 64.1% increase from 2021.
  • Freeline Therapeutics Holdings plc annual Payments to Acquire Property, Plant, and Equipment for 2021 was $4.27M, a 70.1% increase from 2020.
  • Freeline Therapeutics Holdings plc annual Payments to Acquire Property, Plant, and Equipment for 2020 was $2.51M, a 15.6% decline from 2019.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Freeline Therapeutics Holdings plc Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $392K -$134K -25.5% Jan 1, 2023 Mar 31, 2023 6-K 2023-05-30
Q1 2022 $526K -$1.75M -76.9% Jan 1, 2022 Mar 31, 2022 6-K 2023-05-30
Q1 2021 $2.28M +$1.73M +313% Jan 1, 2021 Mar 31, 2021 6-K 2022-05-10
Q1 2020 $552K Jan 1, 2020 Mar 31, 2020 6-K 2021-05-17

Freeline Therapeutics Holdings plc Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $7.01M +$2.74M +64.1% Jan 1, 2022 Dec 31, 2022 20-F 2023-04-04
2021 $4.27M +$1.76M +70.1% Jan 1, 2021 Dec 31, 2021 20-F 2023-04-04
2020 $2.51M -$464K -15.6% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-04
2019 $2.98M -$737K -19.8% Jan 1, 2019 Dec 31, 2019 20-F 2022-03-31
2018 $3.71M Jan 1, 2018 Dec 31, 2018 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.